Sign In

Judit Anido Folgueira

Chief Executive Officer at Nuage Therapeutics

Judit Anido Folgueira is a prominent figure in the biotechnology sector, currently serving as the Co-Founder, CEO, and Board Member at Nuage Therapeutics, a company focused on developing small molecule modulators targeting disordered proteins for challenging medical conditions. She has been in this role since 2022, following her involvement in the company's establishment in 2021.12

Background and Education

Anido Folgueira holds a PhD in Biology from the University of Barcelona and an MBA from Duke University. Her academic background equips her with a robust understanding of both scientific and business aspects of biotechnology.13

Professional Experience

Before her tenure at Nuage Therapeutics, Judit was the Co-Founder and CEO of Mosaic Biomedicals, where she developed innovative cancer therapies. Following a merger with Northern Biologics, she became the Vice-President of Operations and Corporate Affairs there, contributing to significant corporate transitions when their assets were acquired by major pharmaceutical companies like Boehringer Ingelheim and AstraZeneca.124

Additionally, she has served as the CEO and President of CataloniaBio & HealthTech, representing Catalan health sector companies. This role further highlights her leadership capabilities within the biotech community.1

Key Contributions

Under her leadership, Nuage Therapeutics aims to leverage advanced chemical biology techniques to create selective drugs that can significantly improve patient outcomes. The company has gained recognition for its innovative approach to drug development, particularly focusing on proteins with disordered regions.1

Anido Folgueira's extensive experience and strategic vision continue to shape Nuage Therapeutics as a key player in the biotech industry.

Highlights

Jun 21 · linkedin

🚀 Nuage Therapeutics raises €12M in Seed Financing led by Sofinnova Partners and Asabys Partners. The financing will advance the lead program, for castration resistant prostate cancer, and validate Nuage's drug discovery platform.   We are thrilled to welcome Maina Bhaman, partner at Sofinnova Partners as member of our Board of Directors.   Learn more on our website: https://nuagetx.com/

#biotechnology #cuttinedgescience #innovation #IDPs #biomolecularcondensates #startup #health #oncology #patients #drugdiscovery #SeriesSeed

Apr 13 · linkedin

I will be attending Bio€quity Europe 2023 in Dublin on May 14-16, 2023. Looking forward to see my colleagues in Dublin. Send me a message if you want to meet there!

Related Questions

What are Judit Anido Folgueira's key achievements at Nuage Therapeutics?
How did Judit Anido Folgueira's experience at Mosaic Biomedicals influence her role at Nuage Therapeutics?
What is Judit Anido Folgueira's educational background and how has it impacted her career?
What are the main challenges Judit Anido Folgueira has faced as CEO of Nuage Therapeutics?
How did Judit Anido Folgueira contribute to the success of CataloniaBio & HealthTech?
Judit Anido Folgueira
Judit Anido Folgueira, photo 1
Judit Anido Folgueira, photo 2
Add to my network

Location

Greater Barcelona Metropolitan Area